NDC 59930-1647-2 - Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59930-1647
- Requested NDC
- 59930-1647-2
- Package NDCs from labels
- 59930-1647-2
- Manufacturer
- Bausch & Lomb Incorporated
- Effective date
- 2008-09-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Sulfate - Bausch & Lomb Incorporated | Bausch & Lomb Incorporated | 2008-09-02 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59930-1647-2 | Albuterol Sulfate | 20 mL in 1 BOTTLE, GLASS | SOLUTION | 20 | 1 | |
| 59930-1647-2 | Albuterol Sulfate | 1 in 1 CARTON | SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59930-1647 | ALBUTEROL SULFATE SOLUTION [BAUSCH & LOMB INCORPORATED] | 1 | 2 package rows | 20090105_D476C926-4C3D-4C33-B244-3B58E988ECB3.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALBUTEROL SULFATE | ACTIVE INGREDIENT | 021SEF3731 | ALBUTEROL SULFATE SOLUTION [BAUSCH & LOMB INCORPORATED] | 1 | |
| ALBUTEROL | ACTIVE MOIETY | QF8SVZ843E | ALBUTEROL SULFATE SOLUTION [BAUSCH & LOMB INCORPORATED] | 1 | |
| Benzalkonium Chloride | INACTIVE INGREDIENT | ALBUTEROL SULFATE SOLUTION [BAUSCH & LOMB INCORPORATED] | 1 | ||
| Sulfuric Acid | INACTIVE INGREDIENT | O40UQP6WCF | ALBUTEROL SULFATE SOLUTION [BAUSCH & LOMB INCORPORATED] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3236f82c-14e9-dfd4-e063-6294a90ac43d | 2026-07-16 | Warnings, Adverse reactions | 245314 |
| Albuterol Sulfate Inhalation Solution, 0.5% | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | fdb4ac5a-bf0d-4896-89f7-1828c081b79e | 2026-04-30 | Warnings, Adverse reactions | 245314 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ecc00500-58b8-491f-80df-dc6c89a08cae | 2025-03-21 | Warnings, Adverse reactions | 245314 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC. | 7f261a9b-65d9-408a-8609-c1b3809b8b4b | 2024-02-21 | Warnings, Adverse reactions | 245314 |
| 2334D859-A344-13DD-4E29-C5F5DC5310BC | D476C926-4C3D-4C33-B244-3B58E988ECB3 | 2008-09-02 | Warnings, Adverse reactions | 2334D859-A344-13DD-4E29-C5F5DC5310BC D476C926-4C3D-4C33-B244-3B58E988ECB3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.